In our study, we found that CO and GSK-3β inhibitor significantly improved the survival of DSS-treated mice by increasing body weight, colon length and histological parameters, suggesting that CO inhalation improved experimental colitis by inhibition of GSK-3β signaling. Here, GSK3B is linked to colitis.